Effect inhaled corticosteroid bone density asthmatic patients pilot study effect long-term inhaled ICS oral corticosteroid OCS therapy bone density single dual photon absorptiometry group asthmatic patients average micrograms/day beclomethasone dipropionate equivalents months months control group asthmatic patients OCS mg prednisone equivalents average months months ICS group average bone densities age sex-matched controls radius spine hip OCS group average bone densities age-matched sex-matched controls identical sites dose-response relationship cumulative dose ICS relative bone density absent study group demonstrable control group asthmatics long-term OCS therapy results ICS therapy OCS bone loss doses subjects Further research single user ICS low bone density measurements biologic variant subgroup patients sensitive systemic effects ICS 